MyFinsight
Home
About
Contact
ebs: the income statement
Download
Download image
Non United States
Government
$4,600K
United States
Government
$9,100K
Non United States
Government
$19,300K
United States
Government
$123,200K
Non United States
Government
$74,200K
United States
Government
$700K
All Other Revenue
$13,700K
Medical
Countermeasures MCMProduct
$142,500K
Commercial Product
$74,900K
Total revenues
$231,100K
(-21.34%↓ Y/Y)
Income (loss) from
operations
$76,500K
(18.60%↑ Y/Y)
Total operating
expenses
$154,600K
(-32.58%↓ Y/Y)
Income (loss) before
income taxes
$57,600K
(-59.55%↓ Y/Y)
Total other income
(expense), net
-$18,900K
(-124.26%↓ Y/Y)
Amortization of intangible
assets
$16,300K
(0.00%↑ Y/Y)
Selling, general and
administrative
$38,900K
(-49.22%↓ Y/Y)
Research and development
$13,500K
(-2.17%↓ Y/Y)
Cost of product and
services sales, net
$85,900K
(-29.93%↓ Y/Y)
Net income (loss)
$51,200K
(-55.40%↓ Y/Y)
Income tax provision
$6,400K
(-76.81%↓ Y/Y)
Other, net
-$3,700K
(-116.89%↓ Y/Y)
Interest expense
$15,200K
(83.13%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Emergent BioSolutions Inc. (EBS)
Emergent BioSolutions Inc. (EBS)